�Latest inquiry into dual-purpose contraceptives and non-hormonal contraception was presented at a major scientific conference in Melbourne.
Laureate Professor John Aitken* from the University of Newcastle and Dr Eva Dimitriadis from Prince Henry's Institute of Medical Research addressed the annual scientific conference of the Society for Reproductive Biology (SRB).
Professor Aitken, a world-leader in reproductive biology, will discourse the want to develop novel, safe, effective, dual-purpose contraceptive agents that combine the bar of gestation with trade protection against sexually transmitted diseases (STDs). His research has explored the development of a birth control device agent that immobilises - but does not kill - sperm. The agent also possesses microbicidal activity simultaneously reducing the risk of infection with sexually transmitted diseases, such as Chlamydia.
At the meeting Dr Eva Dimitriadis, Senior Research Officer at Prince Henry's Institute (PHI), presented a novel advance for new non-hormonal contraceptives for women.
Her work builds upon the need and community interest group to widen the selection of uncommitted female birth control device methods and in developing approaches that do non rely upon a adult female taking stiff hormones each day.
Dr Eva Dimitriadis and her colleagues in the Uterine Biology Group at PHI have identified several "pregnancy blocking" molecules that keep the uterus in a state that prevents pregnancy. Her findings in mice provide proof of principle of this alternate contraception approaching and farther development is planned.
Since a fertile woman's uterus is only receptive to a pregnancy for a few days each month a further potential advantage is that the approach would only need to be timed during this key period.
Source: Katie Porritt
Research Australia
More information
